|
|
|
|
LEADER |
03368 am a22004693u 4500 |
001 |
65580 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Ju, Shulin
|e author
|
100 |
1 |
0 |
|a move to dc.description.sponsorship
|e contributor
|
100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Biology
|e contributor
|
100 |
1 |
0 |
|a Whitehead Institute for Biomedical Research
|e contributor
|
100 |
1 |
0 |
|a Lindquist, Susan
|e contributor
|
100 |
1 |
0 |
|a Lindquist, Susan
|e contributor
|
100 |
1 |
0 |
|a Tardiff, Daniel F.
|e contributor
|
100 |
1 |
0 |
|a Han, Haesun
|e contributor
|
700 |
1 |
0 |
|a Tardiff, Daniel F.
|e author
|
700 |
1 |
0 |
|a Han, Haesun
|e author
|
700 |
1 |
0 |
|a Divya, Kanneganti
|e author
|
700 |
1 |
0 |
|a Zhong, Quan
|e author
|
700 |
1 |
0 |
|a Maquat, Lynne E.
|e author
|
700 |
1 |
0 |
|a Bosco, Daryl A.
|e author
|
700 |
1 |
0 |
|a Hayward, Lawrence J.
|e author
|
700 |
1 |
0 |
|a Brown, Robert H.
|e author
|
700 |
1 |
0 |
|a Lindquist, Susan
|e author
|
700 |
1 |
0 |
|a Ringe, Dagmar
|e author
|
700 |
1 |
0 |
|a Petsko, Gregory A.
|e author
|
245 |
0 |
0 |
|a A Yeast Model of FUS/TLS-Dependent Cytotoxicity
|
260 |
|
|
|b Public Library of Science,
|c 2011-08-31T19:58:32Z.
|
856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/65580
|
520 |
|
|
|a FUS/TLS is a nucleic acid binding protein that, when mutated, can cause a subset of familial amyotrophic lateral sclerosis (fALS). Although FUS/TLS is normally located predominantly in the nucleus, the pathogenic mutant forms of FUS/TLS traffic to, and form inclusions in, the cytoplasm of affected spinal motor neurons or glia. Here we report a yeast model of human FUS/TLS expression that recapitulates multiple salient features of the pathology of the disease-causing mutant proteins, including nuclear to cytoplasmic translocation, inclusion formation, and cytotoxicity. Protein domain analysis indicates that the carboxyl-terminus of FUS/TLS, where most of the ALS-associated mutations are clustered, is required but not sufficient for the toxicity of the protein. A genome-wide genetic screen using a yeast over-expression library identified five yeast DNA/RNA binding proteins, encoded by the yeast genes ECM32, NAM8, SBP1, SKO1, and VHR1, that rescue the toxicity of human FUS/TLS without changing its expression level, cytoplasmic translocation, or inclusion formation. Furthermore, hUPF1, a human homologue of ECM32, also rescues the toxicity of FUS/TLS in this model, validating the yeast model and implicating a possible insufficiency in RNA processing or the RNA quality control machinery in the mechanism of FUS/TLS mediated toxicity. Examination of the effect of FUS/TLS expression on the decay of selected mRNAs in yeast indicates that the nonsense-mediated decay pathway is probably not the major determinant of either toxicity or suppression.
|
520 |
|
|
|a Fidelity Biosciences (Firm)
|
520 |
|
|
|a Fidelity Biosciences (Firm) (Research Inititative)
|
520 |
|
|
|a ALS Therapy Alliance
|
520 |
|
|
|a National Institutes of Health (U.S.) (NIH 1RC1NS06839)
|
520 |
|
|
|a National Institutes of Health (U.S.) (NIH U01NS05225-03)
|
520 |
|
|
|a National Institutes of Health (U.S.) (NIH R01NS050557-05)
|
520 |
|
|
|a National Institutes of Health (U.S.) (NIH 1RC2NS070342-01)
|
520 |
|
|
|a Pierre L. de Bourgknecht ALS Research Foundation
|
520 |
|
|
|a National Science Foundation (U.S.) (NS614192)
|
546 |
|
|
|a en_US
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t PLoS Biology
|